Under construction – not a live service
Sign in
Taking people in NorwayNo phase

Checking carpal tunnel surgery patients for heart amyloidosis

Tests carpal tunnel surgery patients for transthyretin amyloidosis, then follows positive cases.

Plain-language title generated from the registry record
Registry title: ATTR Cardiac Amyloidosis in a Selected Population

Key facts

Where
Ålesund, NorwaySee the site

Where in Norway

  • Ålesund HospitalÅlesund, NorwayTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Helse Møre og Romsdal HF
Trial code
NCT06458374
Record updated
12 August 2026
Original description
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.Read full original descriptionShow less

Prevalence and Long Tem Follow up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Inclusion: Male > 50 years; Female > 60 years; operated CTS at Ålesund Hospital.

Exclusion: Cardiac disease at time of operation for CTS; cannot be followed > 5 years due to other medical conditions; not consented; do not speak Norwegian; secondary cause of CTS as traumatic or rheumatic.

ClinicalTrials.gov NCT06458374